| Subjects |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Social Responsibility- A Definite Aspect of Corporate Image |
|
Subjects - Social Responsibility- A Definite Aspect of Corporate Image
This article will provide brief overview about definition, conceptual views as well as possible environmental actions related to the notion of business’s social responsibility. Example will be cited to highlight suc According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product cessful facilitation of a socially responsible business. With ever increasing concern on environmental hazards and issues related to various products and services, it is becoming an undeniable fact that a business ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in hould ensure its social responsibility to facilitate a societal sensitive corporate image. Koontz & Weihrich (1990) asserts that corporate social responsibility is nothing more than seriously considering the impact lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. of company’s action on society. However a more comprehensive definition refers social responsibility with the degree to which a company recognizes what being a good community and global citizen means and acts accord here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ngly (Slocum, 1995:17). It was further asserted that there are three basic conceptual views of social responsibility are generally acknowledged. First ‘traditional social responsibility’ is referred to the percepti d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro on that by serving the interests of shareholders, organization is fulfilling its social responsibility. Second, ‘stakeholder social responsibility’ perceives that managers and employees have obligations towards iden ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ifiable group (stakeholders) that are affected by or can affect organizational efforts to achieve its goal. The difference here is replacement of group definition ‘shareholder’ with ‘stakeholder’ where latter covers easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi broader range of members including shareholders, customers, competitors, government agencies, unions, employees, debt holders trade unions, suppliers and consumer groups. Third, ‘affirmative social responsibility’ nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically nitiates dimension broader that organizational stakeholders by arguing that business has obligations to avoid problems by anticipating changes in its environment, blending goals with both stakeholders as well as pub and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ lic and promoting their mutual interests (Papers4you.com, 2006). To fulfill environmental obligations, social audit is a tool corporate can adopt. Social audit is to identify, measure, evaluate and more importantly ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi report on with continuous monitoring the effects of organization on society and is not manifested through financial statements (Weiss, 1994) . Organizations may carry various affirmative environmental policies to en ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ure the environmental issues relate dot different areas. For instance in area of accidents, open disclosure of accidents, usage of homogenized standards worldwide can be some options (Papers4you.com, 2006). Pollutio dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ns can be reduced by providing incentives internally as well as externally and green teams can also be evolved. Moreover wastes can be minimized through waste disposal services and taking back it from customers. Sim cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin larly environmentally safe substitutes can be used in product with minimum and safe packaging (Corbett & Wassenhove, 1993). Now considering these standards, example of Body Shop can be taken as most suitable case. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen Body Shop has developed its corporate image as provider of environmentally friendly and natural cosmetics (Slocum, 1995). It was further asserted that company sales and profits were ever rising however the business t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel pposed animal testing, sell most products in reusable bottles with refilling services and always supported recycling process written on their packaging. So the discussion and example of Body Shop asserts that by fu ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust lfilling social responsibility, businesses can win society’s heart and remember customers are always associated with society. References Corbett. C, J, & Wassenhove, L, N, (1993),’The green Fee: Internalizing and y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products perationalizing environmental issues’, California Management Review, Fall 1993, 116:135 Koontz, H, & Weihrich, ‘ Essentials of Management’, Fifth Edition, New Delhi: Tata McGraw-Hill Publishing Company Papers For . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de You (2006) "P/B/641. Theoretical issues of CSR", Available from http://www.coursework4you.co.uk/sprtbus32.htm [22/06/2006] Papers For You (2006) "C/B/353. Literature Review on CSR", Available from Papers4you.com [2 elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip /06/2006] Slocum, h & Hellriegel, D (1996), ‘Management’, Seventh Edition, Ohio: South-Western College Publishing Weiss J, W, (1994),’Business Ethics: A Managerial Stakeholder’s Approach’, Belmont, Calif: Wadswort tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How You Can Offer Your Clients Voice Mail without Having to Do All the Work IT Usage in the Apparel Industry
|